Bend partners Xcelience to accelerate drug intermediates to clinical trials
The collaboration will deliver drug-development candidates by combining Bend’s problem-solving and formulation or processing expertise for delivering poorly soluble compounds with Xcelience’s early-phase development activities. The program will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.